ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2017 American Transplant Congress » Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I

Date: Saturday, April 29, 2017

Time: 5:30pm-7:30pm

Location: Hall D1

Session Type: Poster Session

Meeting: 2017 American Transplant Congress

5:30pm-7:30pm
A Novel Computational HLA Matching Algorithm for Improving Donor-Recipient Histocompatibility and Graft Outcomes After Kidney Transplantation.

V. Kosmoliaptsis,1 D. Mallon,1 S. Fuggle,2 R. Johnson,2 C. Watson,1 J. Bradley,1 C. Taylor.1

5:30pm-7:30pm
Activated Th1 and Th17 cTFH Phenotype Correlates with DSA Production in Kidney Transplant Recipients.

C. Macedo, P. Fadakar, K. Hadi, B. Ellinof, A. Zeevi, S. Hariharan, D. Metes.

5:30pm-7:30pm
Antibody-Mediated Vascular Rejection of Kidney Allografts: What Does It Happen After 15 Years?

B. Rodriguez Cubillo,1 I. Perez Flores,1 M. Moreno De La Higuera,1 M. Calvo,1 N. Calvo Romero,1 A. Pascual,2 J. Cortes,2 J. Blanco,2 A. Sanchez-Fructuoso.1

5:30pm-7:30pm
Banff 2013 Classification of Renal Allograft Pathology Is Superior to Banff 2007 in Detecting and Managing Milder and Earlier Cases of Antibody-Mediated Rejection.

J. Hassler,1 V. Ariyamuthu,2 A. Hendricks,1 B. Tanriover,2 J. Torrealba.1

5:30pm-7:30pm
Blood Transfusion Before Organ Transplant: Patient Sensitization and Outcomes.

I. Cich, K. Rudser, R. Brown, H. Ibrahim, R. Thorson, J. Patil, G. Loor, M. Hertz, C. Cohn.

5:30pm-7:30pm
C3d-Binding Anti-DQ DSA Is Associated with a High Risk for Late ABMR and Graft Failure in Stable Kidney Transplant Recipients.

D. Lee,1 B. Kim,2 J. Kim,3 I. Kim,4 M. Chun.5

5:30pm-7:30pm
Can Pre-Treatment CDC Titres Predict Graft Outcomes in HLA Incompatible Transplants?

A. Prasad,1 A. Yuvaraj,1 D. Briggs,2 N. Krishnan.1

5:30pm-7:30pm
Chronic Antibody Mediated Rejection (cABMR) in ABO-Incompatible and ABO-Compatible Kidney Transplants: A Single US Center Experience.

S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.

5:30pm-7:30pm
Circulating Donor-Specific Memory B Cells (mBc) Discriminates Kidney Transplant Patients with Histological Lesions of ABMR in Absence of Circulating DSA.

S. Luque,2 M. Lúcia,4 M. Jarque,2 E. Crespo,2 E. Melilli,1 J. Martorell,3 J. Cruzado,1,2 J. Torras,1,2 J. Grinyó,1,2 O. Bestard.1,2

5:30pm-7:30pm
Comparison Between IgG, C1q and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.

M. Moreno Gonzales,1 D. Mitema,2 B. Smith,3 C. Schinstock,3 M. Stegall,3 M. Gandhi.3

5:30pm-7:30pm
Complement Binding Activity (C3d, C1q) of De Novo Donor-Specific HLA Antibody Is Associated with Increased Risk of Antibody-Mediated Rejection in Non-Sensitized Kidney Transplant Recipients.

H. Lee,1 E. Han,1 A.-R. Choi,1 K. Park,2 J. Ryu,2 B. Chung,3 C. Yang,3 E.-J. Oh.1

5:30pm-7:30pm
DSA Presence Does Not Affect Renal Histology and Clinical Outcome in Chronic Active Antibody Mediated Rejection.

K. Sablik,1 M. Clahsen–van Groningen,1 C. Looman,1 J. Damman,1 D. Roelen,2 M. van Agteren,1 M. Betjes.1

5:30pm-7:30pm
Development of De Novo Donor Specific Antibodies (dnDSAs) Not the Presence of Pre-Transplant Donor Specific Antibodies (Pre-DSAs) Increase Rejection Risk in Crossmatch Negative Kidney Transplant Recipients.

H. Khamash, L. Archambault, M. Buras, H. Kosiorek, M. Pando, K. Reddy, B. Kaplan, R. Heilman.

5:30pm-7:30pm
Early Antibody-Mediated Rejection C4d Status Remains a Marker of Prognosis in HLA-Incompatible Kidney Transplantation.

J. Malheiro,1 S. Santos,1 S. Tafulo,2 L. Dias,1 L. Martins,1 J. Ramon,1 A. Castro-Henriques.1

5:30pm-7:30pm
Elevated Circulating AT1R Levels Indicate Heightened Risk for Antibody Mediated Rejection and Graft Failure.

P. Kimball, G. Gupta, F. McDougan.

5:30pm-7:30pm
Gene Expression Signature of Subclinical Allograft Kidney ABMR Compared to Clinical ABMR.

O. Aubert,1 C. Lefaucheur,1 S. Higgins,1 L. Hidalgo,2 J. Duong Van Huyen,1 D. Viglietti,1 X. Jouven,1 D. Glotz,1 C. Legendre,1 P. Halloran,2 A. Loupy.1

5:30pm-7:30pm
Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor Specific Antibodies and HLA Antigen Complexes in the Renal Allograft.

T. Nakamura,1 H. Ushigome,1 K. Watabe,2 Y. Imanishi,2 S. Harada,1 S. Nobori,1 K. Masuda,1 N. Yoshimura.1

5:30pm-7:30pm
HLA Donor-Specific Antibody (DSA) Negative Antibody-Mediated Rejection (AMR): Incidence, Treatment and Outcomes.

R. Redfield, S. Parajuli, W. Zhong, B. Astor, A. Djamali, D. Mandelbrot.

5:30pm-7:30pm
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-CMV IgG, Resulting in Inhibition of Antibody (Ab)-Mediated NK Cell Activation in Kidney Transplant Patients (KTX Pts).

B.-H. Shin,1 S. Ge,1 M. Chu,1 J. Choi,1 L. Winstedt,2 C. Kjellman,2 S. Louie,1 A. Vo,1 A. Peng,1 S. Jordan,1 M. Toyoda.1

5:30pm-7:30pm
Identification of Antibody-Mediated Rejection After Kidney Transplantation by Specific MicroRNAs.

M. Matz,1 F. Heinrich,2 P. Durek,2 C. Lorkowski,1 K. Wu,3 N. Lachmann,4 K. Budde,1 M.-F. Mashreghi.2

5:30pm-7:30pm
Microarray Analysis of Rejection in Formalin-Fixed Paraffin-Embedded Biopsies: Similarities and Disparities with Conventionally Stabilized Biopsies.

K. Famulski, J. Revee, P. Halloran.

5:30pm-7:30pm
Microcirculation Inflammation in Kidney Allograft Biopsies.

M. Giordani,1 M. Bedini Rocca,1 S. Groppa,1 C. Mombelli,1 S. Christiansen,2 M. Ocampo,1 G. Rosa Diez,1 N. Imperiali.1

5:30pm-7:30pm
Mycophenolate Dose Reductions Are Not Associated with De Novo Donor-Specific Antibodies.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.

5:30pm-7:30pm
Poor Prediction of Rejection and Kidney Survival by Donor-Specific-Antibodies Characterization.

L. Couzi,1,2,3 M. Courant,1 J. Visentin,1,2,3 V. Dubois,4 S. Lepreux,1,2 G. Guidicelli,1 O. Thaunat,5,6 P. Merville,1,2,3 J.-L. Taupin.7

5:30pm-7:30pm
Regulatory T Cells Inhibit Plasmablast Formation and IgG Production by Tempering T Follicular Helper Cell Function.

P. Fadakar, C. Macedo, M. Yamada, K. Hadi, D. Metes.

5:30pm-7:30pm
Risk Factors and Consequences of De Novo Anti-HLA Donor Specific Antibodies in Kidney Transplant Recipients: The Force Awakens.

B. Javaid, S. Rosen-Bronson, D. Li, M. Awwad, A. Gilbert, S. Ghasemian, J. Verbesey, P. Abrams, M. Grafals, J. Fenton, C. Cannon, J. Rapisura, J. Moore, M. Cooper.

5:30pm-7:30pm
Risk Factors of Treatment Failure in Antibody Mediated Rejection.

V. Pernin,1 I. Szwarc,1 T. Kanouni,2 V. Garrigue,1 J. Serre,1 S. Delmas,1 G. Mourad,1 M. Le Quintrec.1

5:30pm-7:30pm
Single Nuclear Polymorphisms of Complement Component 4 and Component 5 in Renal Transplant Recipients with Antibody-Mediated Rejection.

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.

5:30pm-7:30pm
Steroid Withdrawal and De Novo Donor-Specific HLA Antibodies in Renal Transplant Patients: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.

J. Alonso-Titos,1 P. Ruiz-Esteban,1 E. Palma,1 V. Lopez,1 A. Caballero,2 M. Leon,3 M. Cobos,4 J. Cruzado,5 J. Sellares,6 A. Torres,4 D. Hernandez.1

5:30pm-7:30pm
Urinary Proteomic Biomarkers Discovery for Prediction of Acute Rejection in Kidney Transplant Recipients.

H.-Y. Jung, R. Kim, S. Park, J. Park, K. Lee, E. Lee, J.-H. Lim, K. Kim, J.-Y. Choi, J.-H. Cho, S.-H. Park, Y.-L. Kim, C.-D. Kim.

« View all sessions from the 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences